InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,635.46
(
0.77%
)
US TECH 100
19,040.00
(
0.99%
)
Dow Jones
41,521.51
(
1.05%
)
Brent Oil
78.65
(
1.58%
)
Bitcoin
60,406.18
(
2.34%
)
Post# of 51153
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

neuroinv

Send PM Follow Ignore
Followers 32
Posts 2552
Boards Moderated 0
Alias Born 07/16/2006

neuroinv

Re: gfp927z post# 27141

Wednesday, 07/01/2009 3:43:59 PM

Wednesday, July 01, 2009 3:43:59 PM

Post# of 51153
re: Acorda
Their priority has been adding commercial-stage products to be sold along side Zanaflex and Fampridine-SR; they have done nothing with those preclinical programs for five years, and probably won't now. But when you have that much cash and this many choices, a surprise is possible. Possible, but unlikely.

NeuroInvestment
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent RSPI News
More RSPI News
InvestorsHub NewsWire

Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM

Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM

ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM

North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM

PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM

Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!